Institute of Medical Microbiology, Virology and Hygiene, University Medicine Rostock, Rostock, Germany.
Department of General, Visceral, Thoracic, Vascular and Transplantation Surgery, University of Rostock, Rostock, Germany.
Appl Environ Microbiol. 2022 Dec 13;88(23):e0030922. doi: 10.1128/aem.00309-22. Epub 2022 Nov 23.
Application of bacteriophages is increasingly being implemented in clinical therapies. Prior susceptibility testing should be regarded as mandatory, but standards are lacking. The objective of this research was to develop a highly standardized methodology to facilitate phage susceptibility testing (PST) in clinical microbiology routine laboratories. Therefore, EUCAST methods established for single disk-based antibiotic susceptibility testing (AST) were adapted. In a first step, basic parameters were evaluated using well-studied Escherichia phage T4-Escherichia coli combinations. In addition, test results were compared to those from conventional spot test and efficiency of plating (EOP) approaches. In a second step, the applicability of the methodology and the most promising test parameters were demonstrated for five other frequently isolated clinical bacterial species and their corresponding phages. At present, the method predominantly leads to qualitative rather than quantitative results. This disk-based approach provides a standardized, easy-to-handle, reproducible and reliable PST protocol by relying on well-established routine procedures in diagnostic laboratories. Application of bacteriophages in clinical therapies is attractive due to increasing rates of isolation of multidrug-resistant bacteria worldwide. As the phage effect is highly specific, prior susceptibility testing of target bacteria is mandatory. Of note, established standards are lacking. In this research, we adapted the single-disk method for antibiotic susceptibility testing to phage susceptibility testing (PST) in order to provide a standardized, easy-to-handle, reproducible, and reliable PST protocol for application in diagnostic routine laboratories.
噬菌体的应用在临床治疗中越来越广泛。之前的药敏试验应该被视为强制性的,但缺乏标准。本研究的目的是开发一种高度标准化的方法,以促进临床微生物学常规实验室中的噬菌体药敏试验(PST)。因此,我们对用于单盘抗生素药敏试验(AST)的 EUCAST 方法进行了改编。在第一步中,我们使用了经过充分研究的大肠杆菌噬菌体 T4-大肠杆菌组合来评估基本参数。此外,我们还将测试结果与传统的点测试和效率平板(EOP)方法进行了比较。在第二步中,我们展示了该方法在其他五种常见分离的临床细菌及其相应噬菌体中的适用性和最有前途的测试参数。目前,该方法主要产生定性结果,而不是定量结果。这种基于平板的方法通过依赖于诊断实验室中已建立的常规程序,提供了一种标准化、易于操作、可重复和可靠的 PST 方案。
由于世界各地分离出越来越多的多药耐药菌,噬菌体在临床治疗中的应用具有吸引力。由于噬菌体的作用具有高度特异性,因此必须对目标细菌进行药敏试验。值得注意的是,目前缺乏既定的标准。在这项研究中,我们改编了单盘抗生素药敏试验方法用于噬菌体药敏试验(PST),以便为诊断常规实验室提供一种标准化、易于操作、可重复和可靠的 PST 方案。